AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
"The next phase for Miami will be an increase in exits"
4
Once $5 billion IPO bound, Cybereason merges with Trustwave amid decline
5
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
More news

Biotech

20 stories about Biotech
גילי רגב מנכ"לית סנוטייז

"Our nasal spray is like a hand sanitizer for your nose and can block 99.9% of Covid-19 viruses," says CEO

13.01.21|Yafit Ovadia
After new Covid-strains emerge, SaNOtize’s nasal spray is being used in clinical trials in the U.K. and Canada, with plans to be rolled out in the U.S. soon
עסק קטן הקמת עסק סטארטאפ תוכנית עסקים קטנים 2

Startup+ Competition: These startups create innovative products for everyday use

14.12.20|Meir Orbach
Reducing the risk of bodies’ rejecting implants, easy-to-use information about real estate data, and a support network for abused women are just some of the tech solutions featured in Calcalist’s Startup+ competition that can be used every day
Yfat Scialom OutSense

Tech in your toilet: OutSense raises $2.2 million for device that tests poo for health risks

09.11.20|James Spiro
Attaching its IoT device to a toilet bowl, bathroom visitors can help catch cancers and other diseases, company aims to create the world’s largest database of human waste
פאריד אל זארוני Fareed Al Zarooni יו"ר AngelWorld BioTech כנס אמירויות

“This is a great opportunity to secure ties and relationships with our cousins in Israel,” says Emirati executive

01.11.20|CTech
"I have seen a lot of projects built on trust in the past and today they are worth billions," says Farid Al Zarooni chairman of AngelWorld BioTech
ד"ר ערן אדן מנכל מי מד MeMed

MeMed analyzes complex immune responses to answer simple health questions

26.10.20|Yafit Ovadia
Growing biotechnology company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers
מימין תומר קריב ו רן נוסבאום מנהלי קרן פונטיפקס

Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold

12.10.20|Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
default image

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
מימין נועם סולומון ו לואיס וולוך

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20|Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
ד"ר יאיר שינדל מוסף שבועי 13.2.20

Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

21.02.20| Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
איל ליפשיץ פלגרין

Peregrine Ventures Raises Fourth $115 Million Fund

09.12.19|CTech
The Israeli medtech venture firm now has over $200 million under management
סטיבן מנושין סטיבן מנוצ'ין שר האוצר ארה"ב

Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch

29.10.19|Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
נאסדק

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

15.10.19|CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
פנאי נתח בשר

Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech

03.10.19|Ori Galor and Tzally Greenberg
The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through
בורסה בורסת תל אביב 5

New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange

02.06.19|Raheli Bindman
As a remote member, Jefferies’ international clients will gain better access to Israeli tech and biotech companies, creating more investment opportunities
שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund

09.04.19|CTech
The fund's portfolio is made up of 11 startups operating at the company’s FutuRx biotech accelerator in the central Israeli town of Ness Ziona
מוסף רפואה מבחנה מבחנות תרופה תרופות בית חולים

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19|CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
נאסד"ק וול סטריט

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19|Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
נאסדק

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
Previous ArticlesMore Articles